Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Dendreon Swings To Profit In Q4 - Quick Facts

RELATED NEWS
Trade DNDN now with 

Dendreon Corp. (DNDN: Quote) reported fourth-quarter profit of $38.1 million or $0.26 per share versus loss of $91.83 million or $0.64 per share a year earlier.

Non-GAAP net income per share-basic was $0.45 versus loss per share-basic of $0.50 last year.

On average, 21 analysts polled by Thomson Reuters expected the company to report loss of $0.23 per share. Analysts' estimates typically exclude special items.

Total revenue surged to $202.15 million from $25 million a year ago. Analysts estimated revenues of $120.80 million.

Product revenue for the quarter was $77 million compared to $25 million in the prior-year quarter.

Click here to receive FREE breaking news email alerts for Dendreon Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
With energy prices showing a significant increase amid rising gasoline prices, the Labor Department released a report on Tuesday showing that U.S. consumer prices rose in line with economist estimates in the month of June. Stocks are likely to move back to the upside in early trading on Tuesday after ending the previous session modestly lower. The major index futures are currently pointing to a higher open for the markets, with the Dow futures up by 55 points. Use of traditional telephony services in the European Union is decreasing as Internet (VoIP) services have become increasingly popular, according to a report on state of EU Telecommunications markets. Tuesday, the European Commission published the 2012 - 2013 report on the telecommunications market and regulation in the EU. The majority of European countries have established broadband plans with
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.